Pegylated bilirubin for the treatment of hyperlipidemia, obesity, fatty liver disease, cardiovascular diseases and type ii diabetes
US-2025281460-A1 · Sep 11, 2025 · US
This page is not indexed by search engines while we improve data quality.
Stec David E patents
Stec David E is listed as an inventor on 4 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Stec David E |
| Total patents | 4 |
| First publication | Feb 14, 2019 |
| Latest publication | Sep 11, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Pegylated bilirubin for the treatment of hyperlipidemia, obesity, fatty liver disease, cardiovascular diseases and type ii diabetes
US-2022142980-A1 · May 12, 2022 · US
Thin molecules for the treatment of obesity and type II diabetes
US-10662153-B2 · May 26, 2020 · US
Thin Molecules for the Treatment of Obesity and Type II Diabetes
US-2019047952-A1 · Feb 14, 2019 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Toledo | 4 |
| Univ Of Mississippi Medical Center | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P3/04 | 4 |
| A61P3/10 | 4 |
| C07D207/44 | 2 |
| A61K47/60 | 2 |
| A61K9/51 | 2 |